Press esc to close search
Our education section provides in-depth guides and articles across a range of topics.
Our glossary is a great place to start if you’re new to the world of investing.
Drug Retail
Sign-Ups For Novo Nordisk's Weight Loss Drug Soar In US
Novo Nordisk's weight loss drug Wegovy experiences booming sign-ups in the US, while facing pricing pressures and emerging competition.
ALT Stock Short Report Raises Concerns over Altimmune's Weight-Loss Drug
Altimmune Inc. faces disappointment with its weight-loss drug, leading to a 19% stock drop. What does this mean for retail investors? Find out here.
Investors Watch as Novo Nordisk Pours Billions into Obesity Drugs
Novo Nordisk invests $2.3 billion in France to expand its weight-loss drug production, marking a significant move in the pharmaceutical industry.
